<DOC>
	<DOCNO>NCT02020317</DOCNO>
	<brief_summary>To investigate impact reminder serum potassium monitoring hyperkalemia alert potassium-increasing drug-drug-interactions .</brief_summary>
	<brief_title>Clinical Decision Support System Quality Assurance Potassium-Increasing Drug-Drug-Interactions</brief_title>
	<detailed_description>The development hyperkalemia potassium-increasing drug-drug-interactions ( DDIs ) associate ( ) unknown elevate serum potassium level onset treatment ( ii ) insufficient monitor serum potassium therapy . However , potassium-increasing DDIs frequently start despite unknown elevate serum potassium level , monitoring interval often exceed 48 hour . This study investigate impact reminder serum potassium monitoring hyperkalemia alert . Both reminder alert display electronic patient chart in-patients treat potassium-increasing DDIs .</detailed_description>
	<mesh_term>Hyperkalemia</mesh_term>
	<criteria>Inclusion criterion : inpatient treat concurrent potassiumincreasing drug Exclusion criterion : outpatient ; inpatient ward without computerized physician order entry ( i.e . patient treat ICU )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>drug interaction</keyword>
	<keyword>Drug Monitoring</keyword>
	<keyword>Potassium</keyword>
	<keyword>Hyperkalemia</keyword>
</DOC>